C
Cheryl Gillett
Researcher at King's College London
Publications - 146
Citations - 12223
Cheryl Gillett is an academic researcher from King's College London. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 52, co-authored 136 publications receiving 11077 citations. Previous affiliations of Cheryl Gillett include Guy's and St Thomas' NHS Foundation Trust & Guy's Hospital.
Papers
More filters
Journal ArticleDOI
mRNA expression profiling of phyllodes tumours of the breast: identification of genes important in the development of borderline and malignant phyllodes tumours.
A. M. Jones,Richard Mitter,Richard Poulsom,Cheryl Gillett,Andrew M. Hanby,I. P. M. Tomlinson,Elinor J. Sawyer,Elinor J. Sawyer +7 more
TL;DR: expression of PAX3, SIX1, TGFB2 and HMGA2 in the stromal component of PTs was associated with the borderline/malignant phenotypes, and these four genes may be important in the transition from the benign to borderline/ malignant phenotype.
Proceedings ArticleDOI
Towards high-throughput FLIM for protein-protein interaction screening of live cells and tissue microarrays
Paul R. Barber,G P Pierce,Simon Ameer-Beg,Daniel R. Matthews,Leo M. Carlin,Melanie Keppler,M. Kelleher,Frederic Festy,Cheryl Gillett,R. Springall,Tony Ng,Borivoj Vojnovic +11 more
TL;DR: Novel hardware and software with a modular approach and scripting abilities allow us to work towards speed-optimized acquisition and ease of use to bring FLIM into the high-throughput regime.
Journal ArticleDOI
Time-related effects of estrogen withdrawal on proliferation- and cell death-related events in MCF-7 xenografts.
Simone Detre,Janine Salter,Diana M. Barnes,Sharon Riddler,Margaret Hills,Stephen R. D. Johnston,Cheryl Gillett,Roger A'Hern,Mitch Dowsett +8 more
TL;DR: The results provide a framework for the use of certain proliferation‐ and cell death‐related biological parameters after hormone withdrawal from estrogen‐dependent MCF‐7 xenografts in athymic nude mice using immunohistochemical techniques in comparisons of hormonal agents for human breast cancer treatment.
Journal ArticleDOI
KiSl—A novel monoclonal antibody which recognizes proliferating cells: Evaluation of its relationship to prognosis in mammary carcinoma
Steven A. Sampson,H. Kreipe,Cheryl Gillett,P. Smith,Murid A. Chaudary,Ashraf Khan,Kimberly Wicks,Reza Parwaresch,Diana M. Barnes +8 more
TL;DR: KiS1 is a valuable new antibody which affords useful prognostic information in breast carcinoma and may be of particular use in the study of small lesions such as those identified in the Breast Cancer Screening Programme.
Journal ArticleDOI
Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast
Elinor J. Sawyer,Rebecca Roylance,Christos Petridis,Mark N. Brook,Salpie Nowinski,Efterpi Papouli,Olivia Fletcher,Sarah E Pinder,Andrew M. Hanby,K. Kohut,Patricia Gorman,Michele Caneppele,Julian Peto,Isabel dos Santos Silva,Nichola Johnson,Ruth Swann,Miriam Dwek,K. A. Perkins,Cheryl Gillett,Richard S. Houlston,Gillian Ross,Paolo De Ieso,Melissa C. Southey,John L. Hopper,Elena Provenzano,Carmel Apicella,Jelle Wesseling,Sten Cornelissen,Renske Keeman,Peter A. Fasching,Peter A. Fasching,Sebastian M. Jud,Arif B. Ekici,Matthias W. Beckmann,Michael J. Kerin,Federick Marme,Andreas Schneeweiss,Christof Sohn,Barbara Burwinkel,Pascal Guénel,Pascal Guénel,Thérèse Truong,Thérèse Truong,Pierre Laurent-Puig,Pierre Kerbrat,Stig E. Bojesen,Børge G. Nordestgaard,Sune F. Nielsen,Henrik Flyger,Roger L. Milne,Jose Ignacio Arias Perez,Primitiva Menéndez,Javier Benitez,Hermann Brenner,Aida Karina Dieffenbach,Volker Arndt,Christa Stegmaier,Alfons Meindl,Peter Lichtner,Rita K. Schmutzler,Magdalena Lochmann,Hiltrud Brauch,Hiltrud Brauch,Hans Fischer,Yon Ko,Heli Nevanlinna,Taru A. Muranen,Kristiina Aittomäki,Carl Blomqvist,Natalia Bogdanova,Thilo Dörk,Annika Lindblom,Sara Margolin,Arto Mannermaa,Vesa Kataja,Veli-Matti Kosma,Jaana M. Hartikainen,Georgia Chenevix-Trench,Diether Lambrechts,Caroline Weltens,Erik Van Limbergen,Sigrid Hatse,Jenny Chang-Claude,Anja Rudolph,Petra Seibold,Dieter Flesch-Janys,Paolo Radice,Paolo Peterlongo,Bernardo Bonanni,Sara Volorio,Graham G. Giles,Graham G. Giles,Gianluca Severi,Gianluca Severi,Laura Baglietto,Laura Baglietto,Catriona McLean,Christopher A. Haiman,Brian E. Henderson,Fredrick R. Schumacher,Loic Le Marchand,Jacques Simard,Mark S. Goldberg,Martine Dumont,Vessela N. Kristensen,Robert Winqvist,Katri Pylkäs,Arja Jukkola-Vuorinen,Saila Kauppila,Irene L. Andrulis,Julia A. Knight,Gord Glendon,Anna Marie Mulligan,Peter Devillee,Rob A. E. M. Tollenaar,Caroline M. Seynaeve,Mieke Kriege,Jonine D. Figueroa,Stephen J. Chanock,Mark E. Sherman,Maartje J. Hooning,Antoinette Hollestelle,Ans M.W. van den Ouweland,Carolien H.M. van Deurzen,Jingmei Li,Kamila Czene,Keith Humphreys,Angela Cox,Simon S. Cross,Malcolm W.R. Reed,Mitul Shah,Anna Jakubowska,Jan Lubinski,Katarzyna Jaworska-Bieniek,Katarzyna Jaworska-Bieniek,Katarzyna Durda,Anthony J. Swerdlow,Alan Ashworth,Nick Orr,Minouk J. Schoemaker,Fergus J. Couch,Emily Hallberg,Anna González-Neira,Guillermo Pita,M. Rosario Alonso,Daniel C. Tessier,Daniel Vincent,Francois Bacot,Manjeet K. Bolla,Qin Wang,Joe Dennis,Kyriaki Michailidou,Alison M. Dunning,Per Hall,Doug Easton,Paul D.P. Pharoah,Marjanka K. Schmidt,Ian Tomlinson,Montserrat Garcia-Closas +158 more
TL;DR: Data provide evidence for overlapping, but distinct etiological pathways within ER+ breast cancer between morphological subtypes and for the first time that common breast cancer polymorphisms predispose to LCIS.